For home parenteral nutrition, PICCs should be used for short-term therapy
the ONA take:
According to a new study published in the Journal of Parenteral and Enteral Nutrition (JPEN), researchers at Aalborg University in Aalborg, Denmark, have found that using a peripherally inserted central venous catheter (PICC) for one additional infusion day per week significantly reduced the amount of time before a first bloodstream infection.
For the study, researchers sought to examine whether environmental factors have an influence on the amount of time before a first infection in home parenteral nutrition patients.
Researchers enrolled 136 patients suffering from intestinal failure who were receiving home parenteral nutrition. There was a total of 169 tunneled vascular access devices and 126 PICCs used.
Researchers also found that using a tunneled vascular access device managed by a home care nurse increased the incidence of bloodstream infections.
The authors conclude that the PICCs should only be used for short-term therapy and when few infusion days per week are necessary.
Using a peripherally inserted central venous catheter significantly reduced the amount of time before a first bloodstream infection.
- Physical Activity Improves Outcomes for Patients with Breast Cancer and Survivors
- Behavior Pain Assessment Tool Measures Pain In Patients Who Cannot Communicate Verbally
- Whole Genome Sequencing Reveals that 12% of Childhood Cancer Survivors Have Mutations in Genes that Increase Cancer Risk
- Increased 5-Year Survival Rate Seen in NSCLC Subset Treated With Nivolumab
- Novel Test For Multiple Myeloma Uses Microchip, Conventional Blood Sample
- Exercise, Psychological Interventions Better for Cancer Fatigue Than Medications
- ASCO Issues Global Guidance for HPV Vaccination for Cervical Cancer Prevention
- Discharge Events Improved With Standardized Inpatient Palliative Care Consultation
- Little Opposition to Early Palliative Care for Symptom Management in Pediatric Oncology
- Updated ASTRO Guideline Bolsters Safety, Efficacy of Palliative RT for Bone Metastases
- Thyroid Cancer Incidence Increasing Among Younger, Hispanic, African American Populations
- JAK1, JAK2 Inhibition Improves Outcomes in Myeloproliferative Neoplasms, But More Is Needed
- Recommendations Against Contralateral Prophylactic Mastectomy Not Tied to Patient Satisfaction
- Self-efficacy Level Predictive of Likelihood to Follow Through With Colorectal Cancer Screening
- Chronic Myeloproliferative Neoplasms Treatment (Fact Sheet)
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|